Skip to main content
Logo of Goethe university

From Paul Ehrlich’s Magic Bullet to Tomorrow’s Cancer Therapies

David Artis (Weill Cornell Medicine, New York, USA) asks a question during one of the discussions.

A Look Back at the 2026 Frankfurt Cancer Conference

Some 300 researchers and clinicians from Germany, Europe, the United States and Canada gathered at Goethe University Frankfurt from September 2 to 4, 2026, for the Frankfurt Cancer Conference, to discuss new approaches to targeted cancer therapies. The conference was organized by Georg-Speyer-Haus and the University Cancer Center (UCT) Frankfurt.

In his opening remarks, Prof. Dr. Florian Greten, chair of the organizing committee, traced Frankfurt’s long tradition of cancer research back to 1906. That year, the Georg-Speyer-Haus opened under its first director, Paul Ehrlich, while the Institute for Experimental Cancer Research began its work in Heidelberg. The two openings prompted the first international conference on cancer research, held jointly in both cities exactly 120 years ago. Greten recalled Ehrlich’s later development of Salvarsan, one of the first drugs designed to target a specific pathogen and a milestone in modern chemotherapy. This legacy inspired the conference theme, “Translating Paul Ehrlich’s Magic Bullet Into Novel Targeted Therapies,” which focused on increasingly precise cancer treatments.

Two keynote lectures by Prof. Dr. Carl June of the University of Pennsylvania in Philadelphia and Prof. Dr. Douglas Hanahan of the Ludwig Institute for Cancer Research in Lausanne, Switzerland, framed three days of scientific exchange. More than 30 talks explored current developments and challenges in cancer research and treatment, with sessions on immuno-oncology, drug development, tumor plasticity, the tumor microbiome, hematologic diseases and metastasis. Presentations ranged from fundamental biological mechanisms to their translation into new treatments for different types of cancer.

Early-career researchers also presented their work in two poster sessions. Marco Jessen of the Leibniz Institute on Aging, Fritz Lipmann Institute in Jena, and Thi Trang Le of Tübingen University Hospital received poster prizes supported by the Friends and Supporters of the Georg-Speyer-Haus. A career event organized by the Mildred Scheel Early Career Center Frankfurt-Marburg gave young researchers a chance to meet and talk with experienced medical scientists and clinician-scientists Prof. Dr. Maria Sibilia of the Medical University of Vienna and Prof. Dr. Ihsan Ekin Demir of TUM University Hospital in Munich.

The conference showcased Frankfurt’s cancer research, from basic science through clinical practice. It was supported by the Georg-Speyer-Haus, Goethe University Frankfurt and their joint research networks: the German Cancer Consortium (DKTK), the LOEWE Center Frankfurt Cancer Institute (FCI) and the LOEWE research focus CARISMa.

“The Frankfurt Cancer Conference provided an impressive picture of the remarkable diversity of cancer research in Frankfurt and its close links with the international cancer research community. Bringing together leading scientists from different institutions, countries and disciplines created an excellent environment for exchanging ideas and developing new collaborations to advance the cancer treatments of the future,” Prof. Dr. Florian Greten said.

 

Johanna Mirsch

A Look Back at the 2026 Frankfurt Cancer Conference